Ocugen, Inc

$0.295
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0026 (+0.90%) Today
+$0.003 (+1.03%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Ocugen, Inc and other stocks, options, and ETFs commission-free!

About OCGN

Ocugen, Inc. engages in the development and commercialization of therapies for eye diseases. Its pipeline includes OCU400, OCU410, OCU200, OCU200, and OCU300. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. The listed name for OCGN is Ocugen, Inc. Common Stock.

CEO
Shankar Musunuri
Employees
16
Headquarters
Malvern, Pennsylvania
Founded
2013
Market Cap
47.31M
Price-Earnings Ratio
Dividend Yield
Average Volume
12.77M
High Today
$0.2986
Low Today
$0.29
Open Price
$0.29
Volume
7.80M
52 Week High
$0.9577
52 Week Low
$0.17

Collections

OCGN Earnings

-$3.55
-$2.07
-$0.59
$0.89
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 26, Pre-Market

You May Also Like